All industries have been impacted by Coronavirus.
However, Covid-19 outbreak impact on MedTech industry is even more profound and extreme, from re-directed efforts towards respirators or protective devices on one hand, to delayed or stopped elective procedures and dramatically reduced patient visits to health practitioners and hospitals.
Check the operational and financial impact on top 30 companies, prepared by MedTech Dive, and prepare how to adapt and re-start.
How will Covid-19 outbreak impact Pharma and MedTech sales?
J&J forecast shared during the company’s first-quarter conference call give first clues: increased OTC sales, stable Rx, hardest impact on medical devices.
#covid19outbreak #pharma #medtech Continue reading
As countries anticipate what is next, Asia, Europe prepare for post-Covid new normal: increased state intervention, heavy digitalization, regionalized logistics.
#covid19outbreak #commercialization Continue reading
Fast and accurate Covid-19 mass-screening will be critical to identify immunized patients, isolate asymptomatic ones, and allow step-wise economic re-start. However, accuracy of current tests is questioned. #covid19outbreak #covidtesting Continue reading
As deaths rebound in France, Spain, and continue increasing in UK, US, loosening Covid-19 confinement sound premature. #covid19outbreak Details of reduced confinement measures taken by key countries: continue reading
High level of COVID-19 tests per capita have proved beneficial for South Korea, Germany, and now Italy. Significantly lower levels in France, UK and US are worrying.
Data source: ourworldindata.org
Germany COVID-19 fatality rate is among the lowest (0.6% as of March 27, vs 10% in Italy, 5% in France and UK). Key reasons are more testing, higher number or critical care beds, patients demographic and distribution. #covid19outbreak #patientoutcomes Continue reading More details: https://lnkd.in/dc58Q_A See also: https://lnkd.in/dsb_eUJ
With urgent need for patient-HCP contact and symptom-checking despite confinement, usage of telemedicine platforms is skyrocketing #digitalhealth #covid19outbreak #healthtech Digital health platform such as Push Doctor, Doctolib, Kry/Livi or Ada Health have existing for some time, offering services such as doctor-patient appointment, teleconsultation or symptom-checking.
Covid-19 is now acting as a catalyst for those platforms, multiplying usage by 50% or 100% in the past 2
Experts offer 6 recommendations to guide healthcare providers in a paper published by the New England Journal of Medicine. #Covid19outbreak Here are those 6 key principles: - among sick patients, favor those who can recover if treated - give front-line healthcare workers priority - don't follow "first come, first served" principle for equity - adapt priorities based on intervention - prioritize patients participating trials - don't differentiate between COVID-19 patients and
This will reduce hospital visits, minimize virus exposure and reduce risk for providers #covid19outbreak #digitalhealth #patientmonitoring Increased use of remote monitoring will allow to reduce hospital visits, consequently reduce risk of exposue the COVID-19, while at the same time reduce the burden on healthcare providers. This extension will be limited to the duration of the public emergency period. Possible consequence might consist of allowing devices originally cleare
COVID-19 is quickly spreading across USA and sheds light on shortcoming of its health care delivery system. #primarycare #healthcaretransformation #covid19outbreak Deficient primary care, lack of reserve capacity, low number of ventilators... Despite many strengths in specialized care, missing basics may soon be impacting. Continue reading
As the Biopharma industry in trying to match the pace of the outbreak, let's recap what are industry’s attempts to fight the pandemic. #covid19outbreak #biopharma #vaccine While Moderna, BioNtech and a few others are racing for COVID-19 vaccine, main treatment hopes are 70-year old Chloroquine, anti-viral Remdesivir, TAK-888 and RNAi therapeutics. Enabling Biopharma industry to win against this pandemic is critical. Continue reading See also, vaccine candidates:
COVID-19 outbreaks pushes life science industry to rethink its operating model. Grounded in home-office, Pharmaceutical reps finally adopt remote interactions with health professionals. #covid19outbreak #gotomarketstrategy #digitaltransformation
We can no longer contain the virus spread and vaccines are months away. We need to focus on slowing down the virus' spread, reducing effects on health care systems, and saving lives. Social distancing, avoiding close proximity between individual is the best defense against COVID-19, and bring an opportunity to work differently. #digitaltransformation #covid19outbreak #remoteteam Europe is now the epicenter of COVID-19 pandemic. According to epidemiology experts up to 50 or
Beyond event cancellations and travel restrictions, COVID-19 crisis gives an opportunity to accelerate digital health transformation and adoption. #digitalhealthcare #covid19outbreak #healthtech According to a survey by McKinsey, more than 70% of businesses say the progress of digital transformation efforts has slowed or stalled at some point, primarily due to resourcing issues, lack of clarity or alignment or poor quality of the digital strategy itself. COVID-19 is major c